Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants

Concern about disappointing results from recent multi-center trials of new antidepressants prompted several ACNP workshops on “improving the technology of clinical trials.” The workshops focused on technical problems, such as patient screening, reliability of clinical ratings, and the role of the pl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2002-09, Vol.27 (3), p.319-328
Hauptverfasser:	Katz, Martin M, Halbreich, Uriel M, Bowden, Charles L, Frazer, Alan, Pinder, Roger M, Rush, A.John, Wheatley, David P, Lebowitz, Barry D
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressant Antidepressant drug development Antidepressants Antidepressive Agents - standards Antidepressive Agents - therapeutic use Biological and medical sciences Clinical methodology Clinical trial Clinical trials Clinical Trials as Topic - methods Clinical Trials as Topic - standards Componential behavioral approach Drug Evaluation - methods Drugs Humans Medical sciences Mental health Neuropharmacology Onset of drug action Patient Selection Patients Pharmacology. Drug treatments Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!